|
Status |
Public on Dec 21, 2021 |
Title |
Combinatorial Immunotherapy Induces Tumor Infiltrating CD8+ T Cells with Distinct Functional, Migratory, and Stem-Like Properties II |
Organism |
Mus musculus |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
This study reveals supeior efficiacy of triple combination treatment (TCT) based on anti-PD-(L)1 and anti-4-1BB/OX40 and describes immunological mechanisms underlying synergism between the treatment components
|
|
|
Overall design |
Using scRNA-Seq of TILs isolated from isotype-treated mice we defined a functional and phenotypic T cell heterogeneity within non treated tumors.
|
|
|
Contributor(s) |
Yang W, Budimir N |
Citation(s) |
34903555 |
|
Submission date |
Jul 29, 2021 |
Last update date |
Dec 22, 2021 |
Contact name |
Wenjing Yanf |
E-mail(s) |
wenjing.yang3@pfizer.com
|
Organization name |
Pfizer
|
Department |
Oncology
|
Street address |
10770 Science Center Drive
|
City |
San Diego |
State/province |
CA |
ZIP/Postal code |
92121 |
Country |
USA |
|
|
Platforms (1) |
GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
|
Samples (1) |
|
This SubSeries is part of SuperSeries: |
GSE181152 |
Combinatorial Immunotherapy Induces Tumor Infiltrating CD8+ T Cells with Distinct Functional, Migratory, and Stem-Like Properties |
|
Relations |
BioProject |
PRJNA750798 |
SRA |
SRP330494 |